Physician profile
Daniel Shouhed
NPI 1740509900
$214,218.15
in general payments reported to CMS, 2019-2025
25 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $23K · 2021: $113K · 2022: $39K · 2023: $1,784 · 2024: $961 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,158 · Travel and Lodging: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,158.03 |
| Travel and Lodging | $1,174.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $198,373.53 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $9,606.52 | 2019-2020 | |
| Medtronic, INC. | $2,568.56 | 2021-2025 | Signia, Sonicision, Progrip |
| Medical Device Business Services, INC. | $831.77 | 2019 | |
| Asensus Surgical, INC. | $824.95 | 2019 | |
| Ethicon US, LLC | $394.29 | 2019-2023 | Stratafix |
| Daiichi Sankyo INC. | $273.73 | 2021-2025 | Injectafer |
| Enterra Medical, INC. | $254.56 | 2022-2024 | |
| Prescient Surgical | $142.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $114.58 | 2019 | |
| Davol INC. | $110.81 | 2021-2024 | Phasix Mesh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.70 | 2019 | |
| Teleflex LLC | $83.18 | 2022-2024 | Titan Sgs, Titan Sgs Standard Gastric Stapler |
| Karl Storz Endoscopy-America | $80.47 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $68.89 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Standard Bariatrics, INC. | $60.17 | 2022 | |
| Intra-Sana Laboratories | $54.35 | 2024-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Activ Surgical, INC. | $48.71 | 2022 | |
| Apollo Endosurgery US INC | $44.49 | 2022 | |
| Lexington Medical, INC. | $40.58 | 2021 | |
| Endogastric Solutions, INC | $39.76 | 2023 | Esophyx |
| Endo Pharmaceuticals INC. | $31.60 | 2021 | |
| Integra Lifesciences Corporation | $29.97 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Precision Medical Products INC. | $22.51 | 2023 | Circul8 Pro |
| Novo Nordisk INC | $20.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Shouhed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.